Stocks · Health care · Pharmaceutical Preparations

BridgeBio Pharma, Inc.

BBIO Clue Score39

United States Fiscal year ends December CIK 0001743881 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Andrew Lo

18 Nov 2025

Director

Sell indirect

30,993

$66.05

$2.05M

Andrew Lo

18 Nov 2025

Director

Sell indirect

24,007

$65.23

$1.57M

Andrew Lo

17 Nov 2025

Director

Sell

3,798

$67.06

$254.68K

Andrew Lo

17 Nov 2025

Director

Sell

36,801

$66.63

$2.45M

Show all 154 transactions →

What was left out

Form 4 filings counted 61

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 128

Sales straight out of an exercise 22

Sales at will 4

Transactions with no price 0

Shares from compensation/vesting 1,246,438

History held since 26 Jun 2018